News

Merck extended the deadlines to allow claimants and their counsel additional time to complete the enrollment process and for the claims administrator and the company to continue to

The study evaluated the safety and immunogenicity of Recothrom for patients undergoing skin grafting for burns. Topical application of Recothrom using a pump spray device was well tolerated

The proceeds will primarily be used to fund R&D aimed at the identification and validation of protein biomarkers with the goal of finding high potential diagnostic candidates. Christopher

After the equity issuance, Bio-Bridge shall control 51% of the outstanding capital stock of the Xinheng Baide Biotechnology (the seller) for a total cash purchase price of RMB6

Following FDA review of this investigational new drug application (IND), the company plans to initiate a Phase I clinical trial of PX-866. Robert Kirkman, president and CEO of

Under the terms of the agreement, all outstanding shares of Cornerstone’s common stock will be converted into and exchanged for shares of Critical Therapeutics’s common stock and all

The Quill Self-Retaining System (SRS) Polydioxanone (PDO) is a longer-lasting absorbable suture, which is typically used for deeper tissue closures. These smaller diameter sizes incorporate a new design

Ms Shi has 10 years’ working experience in the fields of financial control, auditing and business analysis in both China and the US. Since 2005, she has acted

Athena-1 is the first of several Phase IV Letairis (ambrisentan 5mg and 10mg tablets) studies Gilead plans to initiate in 2008 and 2009. Letairis is currently approved as